Table 3.
With mutation and/or CNV* | Without mutation and CNV* | P | ||
---|---|---|---|---|
Sex | Female | 105 | 7 | 0.313 |
Male | 84 | 10 | ||
Age | ≤60 | 93 | 11 | 0.312 |
>60 | 96 | 6 | ||
Histologic diagnosis | DDLPS | 40 | 10 | <0.001 |
UPS | 43 | 1 | ||
MFS | 17 | 0 | ||
LMS | 79 | 1 | ||
MPNST | 4 | 1 | ||
SS | 6 | 4 | ||
Metastatic | YES | 45 | 1 | 0.264 |
NO | 82 | 7 | ||
N/A** | 62 | 9 | ||
Tumor size (cm) | ≥12.7*** | 69 | 11 | 0.040 |
<12.7 | 112 | 6 | ||
N/A** | 8 | 0 | ||
FNCLCC grade | 1 | 13 | 1 | 0.322 |
2 | 100 | 12 | ||
3 | 76 | 4 |
N/A – not applicable.
With mutation and/or copy number variation (CNV): The Cancer Genome Atlas (TCGA) soft tissue sarcoma patients with mutant or CNV or mutant + CNV; Without mutation and CNV: TCGA soft tissue sarcoma patients with neither mutant nor CNV;
ambiguous variables (N/A) were excluded from chi-square test or Fisher exact test;
the average of tumor size is 12.7 cm.